These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29524631)

  • 1. HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1.
    Wang H; Sun W; Sun M; Fu Z; Zhou C; Wang C; Zuo D; Zhou Z; Wang G; Zhang T; Xu J; Chen J; Wang Z; Yin F; Duan Z; Hornicek FJ; Cai Z; Hua Y
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1839-1849. PubMed ID: 29524631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
    Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-myc downstream-regulated gene 1/Cap43 expression promotes cell differentiation of human osteosarcoma cells.
    Matsugaki T; Zenmyo M; Hiraoka K; Fukushima N; Shoda T; Komiya S; Ono M; Kuwano M; Nagata K
    Oncol Rep; 2010 Sep; 24(3):721-5. PubMed ID: 20664979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy.
    Wang H; Li W; Xu J; Zhang T; Zuo D; Zhou Z; Lin B; Wang G; Wang Z; Sun W; Sun M; Chang S; Cai Z; Hua Y
    Cell Death Dis; 2017 Sep; 8(9):e3048. PubMed ID: 28906492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis.
    Han J; Zhang Y; Xu J; Zhang T; Wang H; Wang Z; Jiang Y; Zhou L; Yang M; Hua Y; Cai Z
    Cancer Lett; 2021 Jan; 496():57-71. PubMed ID: 33038488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor promotes tumor progression and contributes to gemcitabine resistance in osteosarcoma.
    Wang S; Wei H; Huang Z; Wang X; Shen R; Wu Z; Lin J
    Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):317-324. PubMed ID: 33432347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
    Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
    J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma.
    Fan GT; Ling ZH; He ZW; Wu SJ; Zhou GX
    Biochem Biophys Res Commun; 2021 May; 554():214-221. PubMed ID: 33813077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
    J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Husmann K; Hess D; Bertz J; Langsam B; Aemisegger C; Ziegler U; Born W; Fuchs B
    Biochim Biophys Acta; 2013 Aug; 1832(8):1173-82. PubMed ID: 23528710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
    Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
    Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.
    Pu Y; Zhao F; Li Y; Cui M; Wang H; Meng X; Cai S
    BMC Cancer; 2017 Jan; 17(1):45. PubMed ID: 28073349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma.
    Yang M; Zhang T; Zhang Y; Ma X; Han J; Zeng K; Jiang Y; Wang Z; Wang Z; Xu J; Hua Y; Cai Z; Sun W
    J Exp Clin Cancer Res; 2021 May; 40(1):166. PubMed ID: 33980265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
    Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
    Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.
    Xu M; Jin H; Xu CX; Sun B; Mao Z; Bi WZ; Wang Y
    Oncotarget; 2014 Oct; 5(19):9472-83. PubMed ID: 25344865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma.
    Wang J; Cao L; Wu J; Wang Q
    Int J Oncol; 2018 Jan; 52(1):77-88. PubMed ID: 29115574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA SNHG7 Promotes the Tumor Growth and Epithelial-to-Mesenchymal Transition via Regulation of miR-34a Signals in Osteosarcoma.
    Deng Y; Zhao F; Zhang Z; Sun F; Wang M
    Cancer Biother Radiopharm; 2018 Nov; 33(9):365-372. PubMed ID: 29989838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMPDH2 mediate radioresistance and chemoresistance in osteosarcoma cells.
    Li HX; Meng QP; Liu W; Li YG; Zhang HM; Bao FC; Song LL; Li HJ
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(20):3038-44. PubMed ID: 25392102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma.
    Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z
    J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene.
    Pu Y; Zhao F; Wang H; Cai S
    Sci Rep; 2017 Mar; 7():44218. PubMed ID: 28281638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.